CBOE GLOBAL MARKETS, INC. Tanzeel Akhtar 6/25/2019 1:18:28 PM
Jaguar Health Inc (NASDAQ: JAGX) said Monday evening it has regained compliance with all applicable Nasdaq Stock Market listing standards.
Jaguar Health says it received a letter from the Nasdaq on June 21, confirming that the bid price deficiency of Jaguar has been fixed, and that the company is in compliance with all applicable listing standards.
Jaguar Health is a pharmaceutical company focused on developing sustainably derived gastrointestinal products.
Jaguar Health shares traded higher by 1.7% at $4.64 at time of publication.
Related Links:
Jaguar Health Spikes 50% After Subsidiary Receives Preclinical Services From NIAID
Acer Therapeutics Shares Plunge On FDA Complete Response Letter
Attachments
- Original document
- Permalink
Disclaimer
CBOE Holdings Inc. published this content on 25 June 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 June 2019 18:55:03 UTC
